Daily Bulletin

Men's Weekly

.

RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients

Recruitment completed for Part A of the Phase 2/3 study of once-daily orally-administered RHB-107 (upamostat) for patients with symptomatic COVID-19 who do not require hospital care

Top-line results for Part A of the study, designed to evaluate safety and tolerability of RHB-107 and dose selection, expected in Q1/ 22

RHB-107 is...

Read more: RedHill Biopharma Announces Last Patient Randomized in Part A of Ongoing Phase 2/3 COVID-19 Study...

Business News

Nutifood Partners With GippsNature for First Product Launch, Eyeing Global Growth

The Victorian Government delegation joined discussions during the visit The first GippsNature product signals a new chapter in Vietnam - Australia dairy ties. A New Cross-Border Dairy Initiative ...

Daily Bulletin - avatar Daily Bulletin

5 Tips for Maintaining Outdoor Furniture in Rentals

Think outdoor furniture is low-maintenance? Tell that to the sun, the rain, and the occasional possum that decides to test it out. If you’re managing a property, that outdoor setup isn’t just for sho...

Daily Bulletin - avatar Daily Bulletin

Finding the Best Removalists in Geelong, Victoria: What You Need to Know

Moving to a new home or office can be both exciting and stressful. The process involves a lot of planning, coordination, and effort to ensure that everything runs smoothly. One of the most important d...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business